HomeOpen Access News

Open Access News

AI tool ‘Consult’ used for first time to analyse public responses in government consultation

Scottish Government trials new AI to speed up policy analysis and cut costs, with promising early results.

Johnson & Johnson vaccine has 66% efficiency in one dose

New clinical trial data shows that the Johnson & Johnson vaccine is able to give 66% protection against COVID in one dose - with an 85% efficiency at the standard double-dose.

Treating bovine tuberculosis (bTB) with artificial intelligence

Craig Rhodes, EMEA Industry Lead for Artificial Intelligence Healthcare and Life Science at NVIDIA, explores how bovine tuberculosis (bTB) can be monitored and treated more effectively and efficiently using Artificial Intelligence (AI).

Domestic abuse services receive £40m to support victims

Specialist support services for victims of rape and domestic abuse will receive an extra £40 million funding boost from the Government.

Childhood trauma linked to multiple sclerosis development

Scientist have found that childhood trauma could affect the development and treatment of multiple sclerosis in adulthood.

The EU authorises AstraZeneca COVID vaccine for use

European regulators have approved their third vaccine, AstraZeneca - which comes after a week of tense communications between the two parties.

Three ways to solve the logistical challenges of giving COVID vaccines

An anonymous Doctor explains their ideas for how the NHS could tackle the significant logistical challenges of giving COVID vaccines.

How to embark on becoming a smart digital city of tomorrow

Harjott Atrii, Executive Vice President and Global Head, Digital Foundation Services, at Zensar, explains how cities can embark on a smart/digital journey.

Horizon Europe reveals five main missions for new funding

The new Horizon Europe programme will pick up where Horizon 2020 left off, with five main missions - cancer, climate change, marine environment, smart cities and food security.

Novavax vaccine is 85.6% efficient against UK COVID mutation

Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.

Green aviation projects to receive £84 million funding boost

Three projects have been awarded £84 million from the Aerospace Technology Institute (ATI) programme to power zero-emissions flights .

How can the finance world transition into sustainable investment?

Professor Dirk Schoenmaker discusses how the world of finance is just beginning to acknowledge to the idea of sustainability - here, he explores what the future could bring.

Overcoming the fear of local government digital transformation

Glen Ocsko, head of local government at Made Tech, discusses why local council departments do not need to live in constant fear of technological innovation.

AI technology can help tackle the cancer care backlog

Hugh Bettesworth, CEO, Mirada Medical, explores how AI autocontouring technology can help tackle the cancer care backlog as a result of the COVID-19 pandemic.

President Biden signs bundle of executive orders on climate change

Yesterday, President Biden signed a slew of executive orders on climate change, describing the new proposals as a way to fight an "existential threat".

CCS and NHS digital launch Digital Capability for Health framework

Crown Commercial Service's have announced that there new Digital Capability for Health framework in collaboration with NHS Digital is now live.

Nature needs legal rights to really protect biodiversity

Professor Dr Tineke Lambooy discusses why granting legal personhood to entities of nature could enable society to protect biodiversity for future generations.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders